Transcenta Holding
A Global Fully Integrated Biotherapeutics Company
China · Founded 2013
- Founded
- 2013
- Business Model
- B2B
- Website
- transcenta.com
About
Transcenta is a global, fully integrated biotherapeutics company spanning antibody discovery, translational research, process development, clinical development, and manufacturing. Its antibody generation platform is based on Immune Tolerance Breaking Technology, producing therapeutic candidates with differentiated biological profiles. Translational research generates PK, PD, toxicology, and immunogenicity data to model clinical responses and guide trial design. Clinical development spans centers in Beijing, Shanghai, Guangzhou, and Princeton, US, supported by a flexible modular manufacturing facility using classical fed-batch and perfusion-based continuous bioprocessing.
Summary
Transcenta Holding is a Biotech company based in China, founded in 2013.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...